IGF1R and breast carcinoma: In addition, BRCA has also been described as a metabolic regulator through its complex interactions with insulin/IGF-1 signaling axis and as transcriptional repressor of the gene IGF1R, main key players in the pathogenesis of T2DM-related complications and in breast cancer onset and progression [68,70].